KUKJEON PHARMACEUTICAL Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	202,373	172,478	306,192	324,839	537,308
Market Cap Growth	-29.12%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	225,334	178,557	319,290	284,635	-
Last Close Price	4040.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	99.34	63.47	36.30	133.06
PS Ratio	1.50	1.26	2.51	3.13	6.30
PB Ratio	2.01	1.77	3.14	3.52	6.46
P/TBV Ratio	2.03	1.80	3.22	3.60	6.50
P/FCF Ratio	192.27	79.52	-	-	-
P/OCF Ratio	52.50	17.19	-	-	176.63
EV/Sales Ratio	1.67	1.31	2.62	2.75	-
EV/EBITDA Ratio	81.44	32.63	33.11	57.72	-
EV/EBIT Ratio	-	486.92	49.05	81.60	-
EV/FCF Ratio	214.09	82.32	-	-	-
Debt / Equity Ratio	0.57	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	19.75	11.94	8.17	12.03	1.09
Debt / FCF Ratio	54.66	30.11	-	-	-
Asset Turnover	0.64	0.62	0.58	0.68	-
Inventory Turnover	4.36	4.22	4.05	4.62	-
Quick Ratio	0.87	0.85	0.94	1.67	2.72
Current Ratio	1.26	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-1.73%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-0.69%	0.10%	1.93%	1.44%	-
Return on Capital (ROIC)	-0.88%	0.14%	2.48%	1.80%	-
Return on Capital Employed (ROCE)	-	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-0.38%	1.01%	1.58%	2.76%	0.75%
FCF Yield	0.52%	1.26%	-14.46%	-9.02%	-1.37%
Dividend Yield	0.25%	0.28%	-	-	-
Payout Ratio	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	9.13%	-	4.23%	-16.16%	-
Total Shareholder Return	9.38%	0.28%	4.23%	-16.16%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.